Tommaso Pollini

94 posts

Tommaso Pollini banner
Tommaso Pollini

Tommaso Pollini

@TomPolli1

Surgeon from the Verona Pancreas Institute | postdoctoral research fellow at UCSF 🇮🇹🇺🇸

Katılım Mart 2013
482 Takip Edilen261 Takipçiler
Tommaso Pollini
Tommaso Pollini@TomPolli1·
What an incredible experience teaching young kids about heart anatomy! Huge thanks to @Maker_MD for bringing the @UCSFSurgery spirit to our community!
Ajay Maker@Maker_MD

Had a fantastic time at Baywood Elementary School Science Night! 🫀✨ Students explored circulation & did hands-on heart dissections. Great way to spark curiosity in science & medicine. Huge thanks to my @UCSFSurgery colleagues who volunteered their time to inspire the next gen!

English
0
0
3
192
Tommaso Pollini
Tommaso Pollini@TomPolli1·
"Trivial" IPMN out on @AGA_Gastro! ⚠️No added risk of PC in subset of IPMN compared to general population!! ➡️If you want to repeat the same analysis on your dataset, you can find the commented R code at github.com/TomPoll/SIR-pa… #SoMe4Surgery
Giovanni Marchegiani@Gio_Marchegiani

"Trivial" IPMNs as potential target of surveillance discontinuation are out now on @AGA_Gastro 🔥 🧐 After 5 years of surveillance their risk comparable to that of the general population depending on 📏 Cyst size 👴 Patient Age But how did we get here? gastrojournal.org/article/S0016-…

English
0
1
15
1.1K
Tommaso Pollini
Tommaso Pollini@TomPolli1·
When you evaluate a pancreatic cyst like this, what is the risk of it being malignant that you share with the patient? In our meta-analysis on 3292 resected MCN the risk was 16%! Read the full text in the link below!
Tommaso Pollini tweet media
English
1
3
18
4.8K
Tommaso Pollini
Tommaso Pollini@TomPolli1·
Check out our latest review on IPMN on @AnnSurgOncol! From epidemiology 🗺️ ➡️ screening impractical! to biomarkers 🧪 ➡️ big steps in recent years! 🔝 Thanks to @paul_wongg and @Maker_MD for the great work! @UCSFSurgery @SocSurgOnc
Paul Wong, MD@paul_wongg

Honored to have been able to contribute to this important review in the Landmark Series regarding IPMN guidelines, surveillance, biomarkers, and more. Thank you to @Maker_MD, @TomPolli1, and @AnnSurgOncol for this opportunity. @UCSFSurgery @SocSurgOnc link.springer.com/article/10.124…

English
0
0
9
988
Tommaso Pollini
Tommaso Pollini@TomPolli1·
It’s very exciting to see new drugs and approaches make a difference for patients! 💊 ➡️ attacking desmoplastic stroma with CEND-1 🔝promising outcome 🤞🏼 !! No dose limiting toxicities !! @LancetGastroHep
The Lancet Gastroenterology & Hepatology@LancetGastroHep

New research – Dean et al – CEND-1 plus nab-paclitaxel and gemcitabine for metastatic #PDAC: a first-in-human, open-label, multicentre, phase 1 study thelancet.com/journals/langa… #GITwitter #PancreaticCancer

English
0
0
6
0
Tommaso Pollini retweetledi
SAGES is in Tampa in 2026!
SAGES is in Tampa in 2026!@SAGES_Updates·
The Supreme Court just ruled 6-3 that you don't really need to establish the Critical View of Safety.
English
1
2
17
0